Universal Ibogaine Inc. (TSXV:IBO)
Canada
· Delayed Price · Currency is CAD 0.0250
0.00 (0.00%)
Feb 3, 2025, 4:38 PM EDT
Universal Ibogaine Revenue
Universal Ibogaine had revenue of 371.60K CAD in the quarter ending January 31, 2025, a decrease of -36.96%. This brings the company's revenue in the last twelve months to 1.90M, down -14.76% year-over-year. In the fiscal year ending July 31, 2024, Universal Ibogaine had annual revenue of 2.33M with 126.32% growth.
Revenue (ttm)
1.90M
Revenue Growth
-14.76%
P/S Ratio
3.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.17M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| WELL Health Technologies | 919.69M |
| Cronos Group | 169.23M |
| Curaleaf Holdings | 1.93B |